샘플 요청 목록

 카트 문의
시장보고서
상품코드
1727400

세계의 치과용 마취제 시장 : 약물 유형별, 투여 경로별, 최종사용자별, 지역별 - 예측(-2030년)

Dental Anesthetics Market by Drug Type (Lidocaine, Mepivacaine, Articaine, Bupivacaine, Mepivacaine, Prilocaine), Route of Administration (Topical, Injectable, Syringes, Needles), End User (Hospitals, Clinics, Others), Region - Global Forecast to 2030
발행일: | 리서치사: MarketsandMarkets | 페이지 정보: 영문 245 Pages | 배송안내 : 즉시배송

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전 세계 치과용 마취제 시장 규모는 2025년 14억 8,000만 달러에서 2030년에는 18억 달러에 달할 것으로 예상되며, 예측 기간 동안 4.0%의 CAGR을 기록할 것으로 예상됩니다.

조사 범위
조사 대상 연도 2024-2030년
기준 연도 2024년
예측 기간 2024-2030년
검토 단위 금액(10억 달러)
부문 약제 종류별, 투여 경로별, 최종사용자별, 지역별
대상 지역 북미, 유럽, 아시아태평양, 기타 지역

세계 치과용 마취제 시장은 치과 질환의 유병률 증가와 치과 시술의 증가에 따라 확대되고 있습니다. 또한, 구강 건강 및 미용 치과의 중요성에 대한 인식이 높아지면서 치과 치료를 받는 사람들이 증가하고 있습니다. 많은 지역에서 소득수준이 향상되고 의료 인프라가 개선되면서 치과치료가 더욱 친숙해졌습니다. 또한, 노인 인구의 증가로 인해 이러한 서비스에 대한 수요가 증가할 것으로 예상됩니다. 그러나 예측 기간 동안 치과 의사 부족과 치과 치료에 대한 보험 적용 제한 등의 문제가 시장 성장을 어느 정도 저해할 수 있습니다.

아르티카인은 다른 유형의 마취제에 비해 많은 장점을 가지고 있기 때문에 예측 기간 동안 가장 높은 CAGR을 경험할 것으로 예상됩니다. 벤젠 고리를 포함하는 다른 아미드계 마취제와 달리 아르티카인은 티오펜 고리를 가지고 있어 지질 용해도가 향상되고 조직과 신경막으로의 침투성이 개선됩니다. 이렇게 경조직과 연조직 모두에 대한 확산성이 향상되어 다른 마취제에서는 신경차단이 필요한 경우가 많은 하악부위 침윤에 특히 효과적입니다. 그 결과, 치과의사들은 아르티카인이 골밀도가 높은 부위에서 더 나은 효과를 보입니다고 말합니다. 또한, 다양한 연구를 통해 노인 및 소아 환자군에서도 적절히 사용했을 때 안전하다는 것이 확인되었습니다. 이러한 장점은 알티카인의 인기 상승에 기여하며 시장 확대를 뒷받침하고 있습니다.

국소 마취제 시장은 치과용 마취제 시장에서 가장 높은 성장세를 보일 것으로 예상되며, 그 원동력은 표준 시술에서 광범위한 사용, 적용의 용이성, 비침습성, 빠른 표면 마취를 제공하는 능력에 기인합니다. 치과 의사들은 젤, 정량적 스프레이, 패치와 같은 새로운 기술을 점점 더 많이 사용하고 있습니다. 또한, 바늘을 사용하지 않는 마취의 도입과 다양한 맛의 국소 마취제의 가용성 또한 도입 증가에 기여하고 있습니다. 국소 마취제는 작용 시간이 짧다는 제약이 있지만, 그 안정성과 다양한 용도가 시장 성장을 견인하고 있습니다.

치과용 마취제에 대한 수요는 주로 라틴아메리카와 아시아태평양의 개발도상국에서 치과 진료소의 성장에 의해 주도되고 있습니다. 베트남, 인도네시아, 인도 등의 국가에서 치과 서비스 접근성이 향상됨에 따라 효과적인 통증 관리가 필요한 수술을 원하는 환자가 증가하고 있습니다. 치과 진료소 확대에 기여하는 주요 요인으로는 중산층의 소득 증가, 도시화, 구강 위생에 대한 인식 증가 등을 꼽을 수 있습니다. 이에 따라 신뢰할 수 있는 국소 마취제 및 국소 마취제에 대한 수요가 증가하고 있습니다.

아시아태평양의 치과용 마취제 시장은 헬스케어의 변화를 반영하는 몇 가지 요인으로 인해 가장 높은 CAGR로 성장할 것으로 예상됩니다. 치과 감염의 유병률 증가와 구강 건강에 대한 인식이 높아짐에 따라 치과 시술에 대한 수요가 증가하고 있습니다. 또한, 이 지역의 인구 증가와 고령화는 의료비 지출 증가에 크게 기여하고 있으며, 쉽게 접근할 수 있고 환자 친화적인 치료 옵션에 대한 필요성이 증가하고 있습니다. 의료 인프라 개선, 가처분 소득 증가, 치과용 마취제의 발전은 아시아태평양의 치과용 마취제 시장의 성장을 촉진할 것으로 예상됩니다.

세계의 치과용 마취제 시장에 대해 조사했으며, 약제 종류별, 투여 경로별, 최종사용자별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 소개

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

  • 소개
  • 시장 역학
  • Porter's Five Forces 분석
  • 규제 분석
  • 업계 동향
  • 상환 시나리오
  • 기술 분석
  • 2025-2026년의 주요 회의와 이벤트
  • 가격 분석
  • 무역 분석
  • 특허 분석
  • 밸류체인 분석
  • 생태계 분석
  • 공급망 분석
  • 사례 연구 분석
  • 고객의 비즈니스에 영향을 미치는 동향/혼란
  • 주요 이해관계자와 구입 기준
  • 인접 시장 분석
  • 미충족 수요/최종사용자 기대
  • AI/생성형 AI가 치과용 마취제 시장에 미치는 영향
  • 2025년 미국 관세의 영향 - 개요

제6장 치과용 마취제 시장(약물 유형별)

  • 소개
  • 리도카인
  • 메피바카인
  • 아티카인
  • 부피바카인
  • 프릴로카인
  • 기타

제7장 치과용 마취제 시장(투여 경로별)

  • 소개
  • 국소 마취제
  • 주사 마취제
  • 주사기
  • 침

제8장 치과용 마취제 시장(최종사용자별)

  • 소개
  • 병원
  • 치과의원
  • 기타

제9장 치과용 마취제 시장(지역별)

  • 소개
  • 유럽
    • 유럽의 거시경제 전망
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 영국
    • 기타
  • 북미
    • 북미의 거시경제 전망
    • 미국
    • 캐나다
  • 아시아태평양
    • 아시아태평양의 거시경제 전망
    • 한국
    • 일본
    • 중국
    • 인도
    • 호주
    • 기타
  • 라틴아메리카
    • 라틴아메리카의 거시경제 전망
    • 브라질
    • 아르헨티나
    • 멕시코
    • 기타
  • 중동 및 아프리카
    • 시장 확대에 따라 서비스 취약 지역에 대한 관심 증가
    • 중동 및 아프리카의 거시경제 전망
  • GCC 국가
    • 시장을 활성화 시키기 위한 공공 캠페인이나 교육 프로그램 증가
    • GCC 국가의 거시경제 전망

제10장 경쟁 구도

  • 소개
  • 주요 진출 기업 전략/강점
  • 시장 점유율 분석
  • 기업 평가 매트릭스 : 주요 진출 기업, 2024년
  • 기업 평가 매트릭스 : 스타트업/중소기업, 2024년
  • 기업 평가와 재무 지표
  • 브랜드/제품 비교
  • 경쟁 시나리오

제11장 기업 개요

  • 주요 진출 기업
    • SEPTODONT HOLDING
    • DENTSPLY SIRONA
    • PIERREL
    • HUONS GLOBAL
    • NORMON
    • DFL INDUSTRIA E COMERCIO S/A
    • ULTRADENT PRODUCTS INC.
    • PRIMEX PHARMACEUTICALS
    • KEYSTONE INDUSTRIES
    • CLARBEN LABORATORIES
    • HIKMA PHARMACEUTICALS PLC
    • ZEYCO
    • NEW STETIC S.A.
    • CETYLITE, INC.
    • ICPA HEALTH PRODUCTS LIMITED
  • 기타 기업
    • CENTRIX, INC.
    • ZYMETH PHARMACEUTICAL
    • DMG AMERICA LLC
    • GC SHOWAYAKUHIN CORPORATION
    • YOUNG INNOVATIONS, INC.
    • CROSSTEX INTERNATIONAL, INC.
    • MARK3(CARGUS INTERNATIONAL, INC.)
    • J. MORITA CORP.
    • KULZER GMBH
    • INTEGRA LIFESCIENCES CORPORATION

제12장 부록

ksm 25.06.04

The global dental anesthetics market is projected to reach USD 1.80 billion by 2030 from USD 1.48 billion in 2025, at a CAGR of 4.0% during the forecast period.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2024-2030
Units ConsideredValue (USD billion)
SegmentsDrug Type, Route of Administration, End User, and Region
Regions coveredNorth America, Europe, APAC, RoW

The global market for dental anesthetics is expanding due to a rising incidence of dental issues, which has led to an increase in dental procedures. Furthermore, there is greater awareness of the importance of oral health and cosmetic dentistry, prompting more individuals to seek dental treatments. Improved income levels and enhanced healthcare infrastructure in many regions make dental care more accessible. Additionally, the growing elderly population is expected to drive up demand for these services. However, during the projected period, challenges such as a shortage of dental practitioners and limited insurance coverage for dental procedures may hinder market growth to some extent.

"Articaine is expected to grow at the highest CAGR during the forecast period."

Articaine is projected to experience the highest CAGR during the forecast period due to its numerous advantages over other types of anesthetics. Unlike other amide anesthetics that contain a benzene ring, articaine features a thiophene ring, which leads to increased lipid solubility and improved penetration into tissues and nerve membranes. This enhanced diffusion through both hard and soft tissues makes articaine particularly effective for mandibular infiltrations, where nerve blocks are often required with other anesthetics. Consequently, dentists find that articaine performs better in areas with dense bone structures. Additionally, various studies have confirmed its safety profile when used appropriately, even among elderly and pediatric patient populations. These advantages contribute to the growing popularity of articaine and support its market expansion.

"The topical anesthetics segment is expected to grow at the highest CAGR in the dental anesthetics market, by route of administration."

The topical anesthetics market is projected to experience the highest growth in the dental anesthetics market, driven by their widespread use in standard procedures, ease of application, non-invasiveness, and ability to provide quick surface anesthesia. Dentists increasingly utilize new technologies such as gels, metered-dose sprays, and patches. Additionally, the introduction of needle-free anesthesia and the availability of topical anesthetics in various flavors contribute to their increased adoption. Although topical anesthetics are limited by their short duration of action, their reliability and broad range of applications continue to fuel market growth.

"Based on end users, the dental clinics segment is expected to dominate the dental anesthetics market during the forecast period."

The demand for dental anesthetics is primarily driven by the growth of dental clinics in developing regions of Latin America and the Asia Pacific. As dental services become more accessible in countries such as Vietnam, Indonesia, and India, a greater number of patients are seeking surgeries that require effective pain management. Key factors contributing to the expansion of dental clinics include rising incomes among the middle class, urbanization, and an increasing awareness of oral health. Consequently, there is a growing need for reliable topical and local anesthetics, as more dental clinics now offer restorative and cosmetic procedures.

"The Asia Pacific is expected to register the highest CAGR in the dental anesthetics market during the forecast period."

The dental anesthetics market in the Asia Pacific region is expected to grow at the highest CAGR due to several factors that reflect the changing landscape of healthcare. The rising prevalence of dental infections and greater awareness of oral health drive the demand for dental procedures. Additionally, the region's large and aging population significantly contributes to increased healthcare spending, which boosts the need for easily accessible and patient-friendly treatment options. Improvements in healthcare infrastructure, higher disposable incomes, and advancements in dental anesthetics will also likely fuel growth in the Asia Pacific dental anesthetics market.

A summary of the main supply-side participants in the dental anesthetics market is provided below for this report:

  • By Company Type: Tier 1 (35%), Tier 2 (40%), and Tier 3 (25%)
  • By Designation: C-level Executives (20%), D-level Executives (35%), and Others (45%)
  • By Region: North America (25%), Europe (23%), Asia Pacific (28%), Latin America (17%), Middle East & Africa (7%)

The prominent players in the global dental anesthetics market are Septodont Holding (France), DENTSPLY SIRONA (US), Pierrel (Italy), Huons Global (South Korea), Normon (Spain), DFL Industria e Comercio S/A (Brazil), Ultradent Products Inc. (US), Hikma Pharmaceuticals Plc (UK), Clarben Laboratories (Spain), New Stetic S.A (Colombia), Primex Pharmaceuticals (Switzerland), Keystone Industries (US), Centrix, Inc. (US), GC SHOWAYAKUHIN CORPORATION (Japan), DMG America LLC (US), Zeyco (Mexico), Zymeth Pharmaceutical (India), Cetylite, Inc. (US), ICPA Health Products Limited (India), Crosstex International, Inc. (US), Young Innovations, Inc. (US), Mark3 (Cargus International, Inc.) (US), J.Morita Corp. (Japan), Kulzer GmbH (Germany), and Integra Lifesciences Corporation (US).

Research Coverage

The market study focuses on the dental anesthetics market across various segments. Its purpose is to estimate the market size and growth potential across different categories, including drug type, route of administration, end user, and geographic region. Additionally, the study includes a comprehensive competitive analysis of the key players in the market, along with their company profiles. This analysis features important observations regarding their product offerings, recent developments, and key strategies in the market.

Reasons to Buy the Report

The report provides valuable information for market leaders and new entrants in the dental anesthetics market, offering approximate revenue figures for both the overall market and its subsegments. It enables stakeholders to understand the competitive landscape, which can help them better position their businesses and develop effective go-to-market strategies. Additionally, the report offers insights into the current state of the market, including critical drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:

  • Analysis of key drivers (increasing patient pool for dental treatments, increasing demand for advanced cosmetic dental procedures, and technological advancements in anesthetic delivery), restraints (potential adverse effects), opportunities (rising number of DSOs and growing private equity investments, emerging markets, and growing dental tourism) and challenges (dearth of trained dental practitioners and needle phobia).
  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global dental anesthetics market. The report analyzes this market by drug type, route of administration, end user, and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global dental anesthetics market.
  • Market Development: Thorough knowledge and analysis of the profitable rising markets by drug type, route of administration, end user, and region.
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global dental anesthetics market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED & REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 UNIT CONSIDERED
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RESEARCH LIMITATIONS
    • 2.6.1 SCOPE-RELATED LIMITATIONS
    • 2.6.2 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 DENTAL ANESTHETICS MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION AND COUNTRY (2024)
  • 4.3 DENTAL ANESTHETICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 DENTAL ANESTHETICS MARKET: REGIONAL MIX
  • 4.5 DENTAL ANESTHETICS MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing patient pool for dental treatments
        • 5.2.1.1.1 Dental caries and other dental disorders
        • 5.2.1.1.2 Geriatric population and edentulism
        • 5.2.1.1.3 Periodontal diseases
        • 5.2.1.1.4 Changing lifestyles and unhealthy food habits
      • 5.2.1.2 Increasing demand for advanced cosmetic dental procedures
      • 5.2.1.3 Technological advancements in anesthetic delivery
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Potential adverse effects
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Rising number of DSOs and growing private equity investments
      • 5.2.3.2 Emerging markets
      • 5.2.3.3 Growing dental tourism
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of trained dental practitioners
      • 5.2.4.2 Needle phobia
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.3.2 BARGAINING POWER OF SUPPLIERS
    • 5.3.3 BARGAINING POWER OF BUYERS
    • 5.3.4 THREAT OF SUBSTITUTES
    • 5.3.5 THREAT OF NEW ENTRANTS
  • 5.4 REGULATORY ANALYSIS
    • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.4.2 REGULATORY LANDSCAPE
  • 5.5 INDUSTRY TRENDS
    • 5.5.1 METERED SPRAY SYSTEMS
    • 5.5.2 JET INJECTION SYSTEMS
  • 5.6 REIMBURSEMENT SCENARIO
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 KEY TECHNOLOGIES
      • 5.7.1.1 Vasoconstrictors
      • 5.7.1.2 Buffering agents
    • 5.7.2 COMPLEMENTARY TECHNOLOGIES
      • 5.7.2.1 Computer-controlled local anesthetic delivery (CCLAD) systems
    • 5.7.3 ADJACENT TECHNOLOGIES
      • 5.7.3.1 Reversal agents
  • 5.8 KEY CONFERENCES & EVENTS, 2025-2026
  • 5.9 PRICING ANALYSIS
    • 5.9.1 AVERAGE SELLING PRICE TREND OF INJECTABLE ANESTHETICS, BY REGION
    • 5.9.2 INDICATIVE SELLING PRICE OF DENTAL ANESTHETICS, BY KEY PLAYER
  • 5.10 TRADE ANALYSIS
    • 5.10.1 IMPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020-2024
    • 5.10.2 EXPORT DATA FOR DENTAL ANESTHETICS (HS CODE: 300390), 2020-2024
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENT PUBLICATION TRENDS FOR DENTAL ANESTHETICS
    • 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DENTAL ANESTHETICS MARKET
  • 5.12 VALUE CHAIN ANALYSIS
  • 5.13 ECOSYSTEM ANALYSIS
  • 5.14 SUPPLY CHAIN ANALYSIS
  • 5.15 CASE STUDY ANALYSIS
    • 5.15.1 CASE STUDY 1: ORAQIX TOPICAL ANESTHETIC SIGNIFICANTLY REDUCED PAIN DURING SRP, ENHANCING COMFORT AND PATIENT ACCEPTANCE OF PERIODONTAL THERAPY
    • 5.15.2 CASE STUDY 2: PROCAINE HYDROCHLORIDE PROVIDES SAFE DENTAL ANESTHESIA FOR PATIENT WITH LIDOCAINE ALLERGIES AND SEVERE PHOBIA
    • 5.15.3 CASE STUDY 3: COMPUTERIZED ANESTHESIA SYSTEM AND PATIENT EDUCATION REDUCE DENTAL ANXIETY IN EXTRACTION PROCEDURES
  • 5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.17 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.17.2 BUYING CRITERIA
  • 5.18 ADJACENT MARKET ANALYSIS
  • 5.19 UNMET NEEDS/END-USER EXPECTATIONS
  • 5.20 IMPACT OF AI/GENERATIVE AI ON DENTAL ANESTHETICS MARKET
  • 5.21 IMPACT OF 2025 US TARIFF - OVERVIEW
    • 5.21.1 INTRODUCTION
    • 5.21.2 KEY TARIFF RATES
    • 5.21.3 PRICE IMPACT ANALYSIS
    • 5.21.4 IMPACT ON END-USER INDUSTRIES

6 DENTAL ANESTHETICS MARKET, BY DRUG TYPE

  • 6.1 INTRODUCTION
  • 6.2 LIDOCAINE
    • 6.2.1 RAPID ONSET AND VERSATILE FORMULATIONS TO DRIVE MARKET
  • 6.3 MEPIVACAINE
    • 6.3.1 UPTAKE IN PEDIATRIC & GERIATRIC POPULATIONS TO FUEL MARKET
  • 6.4 ARTICAINE
    • 6.4.1 IDEAL CHOICE FOR EXTENDED SURGICAL PROCEDURES TO PROPEL MARKET
  • 6.5 BUPIVACAINE
    • 6.5.1 PROVISION OF EFFECTIVE POST-OPERATIVE PAIN RELIEF TO SUPPORT MARKET GROWTH
  • 6.6 PRILOCAINE
    • 6.6.1 LOWER TOXICITY PROFILE TO FUEL UPTAKE
  • 6.7 OTHER DRUG TYPES

7 DENTAL ANESTHETICS MARKET, BY ROUTE OF ADMINISTRATION

  • 7.1 INTRODUCTION
  • 7.2 TOPICAL ANESTHETICS
    • 7.2.1 GROWING PATIENT PREFERENCE FOR NEEDLE-FREE ALTERNATIVES TO BOOST DEMAND
  • 7.3 INJECTABLE ANESTHETICS
    • 7.3.1 HIGH PRECISION AND EFFECTIVENESS TO PROPEL MARKET
  • 7.4 SYRINGES
    • 7.4.1 ADVANCEMENTS IN SYRINGE DESIGN TO FUEL MARKET
  • 7.5 NEEDLES
    • 7.5.1 RISING FOCUS ON INFECTION CONTROL AND PATIENT COMFORT TO SUPPORT MARKET GROWTH

8 DENTAL ANESTHETICS MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HOSPITALS
    • 8.2.1 ABILITY TO PURCHASE ADVANCED DENTISTRY EQUIPMENT TO DRIVE MARKET
  • 8.3 DENTAL CLINICS
    • 8.3.1 RISING DEMAND FOR COSMETIC & RESTORATIVE DENTAL PROCEDURES TO PROPEL MARKET
  • 8.4 OTHER END USERS

9 DENTAL ANESTHETICS MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 EUROPE
    • 9.2.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.2.2 GERMANY
      • 9.2.2.1 Favorable government policies for reimbursement to expedite growth
    • 9.2.3 ITALY
      • 9.2.3.1 Rising adoption of digital dentistry techniques to augment growth
    • 9.2.4 SPAIN
      • 9.2.4.1 Presence of well-established dental healthcare infrastructure to foster growth
    • 9.2.5 FRANCE
      • 9.2.5.1 Favorable distribution network and reimbursement scenario to aid growth
    • 9.2.6 UK
      • 9.2.6.1 Booming geriatric population to stimulate growth
    • 9.2.7 REST OF EUROPE
  • 9.3 NORTH AMERICA
    • 9.3.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.3.2 US
      • 9.3.2.1 High per capita income and quality of treatment to support growth
    • 9.3.3 CANADA
      • 9.3.3.1 Rising healthcare expenditure to sustain growth
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 SOUTH KOREA
      • 9.4.2.1 Growing elderly population to fuel market
    • 9.4.3 JAPAN
      • 9.4.3.1 Surge in age-related dental issues to promote growth
    • 9.4.4 CHINA
      • 9.4.4.1 Shift in demographic trend to accelerate growth
    • 9.4.5 INDIA
      • 9.4.5.1 Growing cosmetic dentistry sector to fuel market
    • 9.4.6 AUSTRALIA
      • 9.4.6.1 Increasing access to dental services to favor growth
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Booming dental tourism to contribute to growth
    • 9.5.3 ARGENTINA
      • 9.5.3.1 Growing focus on oral health to propel market
    • 9.5.4 MEXICO
      • 9.5.4.1 Affordable dental care costs to amplify growth
    • 9.5.5 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING FOCUS ON UNDERSERVED AREAS TO BOOST MARKET
    • 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.7 GCC COUNTRIES
    • 9.7.1 INCREASING NUMBER OF PUBLIC CAMPAIGNS AND EDUCATION PROGRAMS TO DRIVE MARKET
    • 9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN DENTAL ANESTHETICS MARKET
  • 10.3 MARKET SHARE ANALYSIS
  • 10.4 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.4.1 STARS
    • 10.4.2 EMERGING LEADERS
    • 10.4.3 PERVASIVE PLAYERS
    • 10.4.4 PARTICIPANTS
    • 10.4.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 10.4.5.1 Company footprint
      • 10.4.5.2 Region footprint
      • 10.4.5.3 Drug type footprint
      • 10.4.5.4 Route of administration footprint
  • 10.5 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.5.1 PROGRESSIVE COMPANIES
    • 10.5.2 RESPONSIVE COMPANIES
    • 10.5.3 DYNAMIC COMPANIES
    • 10.5.4 STARTING BLOCKS
    • 10.5.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.5.5.1 Detailed list of key startups/SMEs
      • 10.5.5.2 Competitive benchmarking of key startups/SMEs
  • 10.6 COMPANY VALUATION & FINANCIAL METRICS
    • 10.6.1 FINANCIAL METRICS
    • 10.6.2 COMPANY VALUATION
  • 10.7 BRAND/PRODUCT COMPARISON
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT LAUNCHES
    • 10.8.2 DEALS
    • 10.8.3 EXPANSIONS
    • 10.8.4 OTHER DEVELOPMENTS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 SEPTODONT HOLDING
      • 11.1.1.1 Business overview
      • 11.1.1.2 Products/Services/Solutions offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Product launches
        • 11.1.1.3.2 Deals
        • 11.1.1.3.3 Expansions
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses & competitive threats
    • 11.1.2 DENTSPLY SIRONA
      • 11.1.2.1 Business overview
      • 11.1.2.2 Products/Services/Solutions offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Deals
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses & competitive threats
    • 11.1.3 PIERREL
      • 11.1.3.1 Business overview
      • 11.1.3.2 Products/Services/Solutions offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Product launches
        • 11.1.3.3.2 Deals
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses & competitive threats
    • 11.1.4 HUONS GLOBAL
      • 11.1.4.1 Business overview
      • 11.1.4.2 Products/Services/Solutions offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Expansions
        • 11.1.4.3.2 Other developments
      • 11.1.4.4 MnM view
        • 11.1.4.4.1 Right to win
        • 11.1.4.4.2 Strategic choices
        • 11.1.4.4.3 Weaknesses & competitive threats
    • 11.1.5 NORMON
      • 11.1.5.1 Business overview
      • 11.1.5.2 Products/Services/Solutions offered
      • 11.1.5.3 MnM view
        • 11.1.5.3.1 Right to win
        • 11.1.5.3.2 Strategic choices
        • 11.1.5.3.3 Weaknesses & competitive threats
    • 11.1.6 DFL INDUSTRIA E COMERCIO S/A
      • 11.1.6.1 Business overview
      • 11.1.6.2 Products/Services/Solutions offered
    • 11.1.7 ULTRADENT PRODUCTS INC.
      • 11.1.7.1 Business overview
      • 11.1.7.2 Products/Services/Solutions offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Deals
        • 11.1.7.3.2 Expansions
        • 11.1.7.3.3 Other developments
    • 11.1.8 PRIMEX PHARMACEUTICALS
      • 11.1.8.1 Business overview
      • 11.1.8.2 Products/Services/Solutions offered
    • 11.1.9 KEYSTONE INDUSTRIES
      • 11.1.9.1 Business overview
      • 11.1.9.2 Products/Services/Solutions offered
    • 11.1.10 CLARBEN LABORATORIES
      • 11.1.10.1 Business overview
      • 11.1.10.2 Products/Services/Solutions offered
    • 11.1.11 HIKMA PHARMACEUTICALS PLC
      • 11.1.11.1 Business overview
      • 11.1.11.2 Products/Services/Solutions offered
    • 11.1.12 ZEYCO
      • 11.1.12.1 Business overview
      • 11.1.12.2 Products/Services/Solutions offered
    • 11.1.13 NEW STETIC S.A.
      • 11.1.13.1 Business overview
      • 11.1.13.2 Products/Services/Solutions offered
    • 11.1.14 CETYLITE, INC.
      • 11.1.14.1 Business overview
      • 11.1.14.2 Products/Services/Solutions offered
    • 11.1.15 ICPA HEALTH PRODUCTS LIMITED
      • 11.1.15.1 Business overview
      • 11.1.15.2 Products/Services/Solutions offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 CENTRIX, INC.
    • 11.2.2 ZYMETH PHARMACEUTICAL
    • 11.2.3 DMG AMERICA LLC
    • 11.2.4 GC SHOWAYAKUHIN CORPORATION
    • 11.2.5 YOUNG INNOVATIONS, INC.
    • 11.2.6 CROSSTEX INTERNATIONAL, INC.
    • 11.2.7 MARK3 (CARGUS INTERNATIONAL, INC.)
    • 11.2.8 J. MORITA CORP.
    • 11.2.9 KULZER GMBH
    • 11.2.10 INTEGRA LIFESCIENCES CORPORATION

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제